Activating the tumor immune response via reactive nitrogen species (RNS) holds promise for advancing tumor immunotherapy. However, current strategies fail to achieve sufficient local RNS concentrations due to the inefficiency of in situ generation within tumor... ...

请注册登录后继续浏览